CGC
HealthcareCanopy Growth Corporation · Drug Manufacturers - Specialty & Generic · $440M
What is Canopy Growth Corporation?
Canopy Growth Corporation is a Canadian cannabis company producing and selling recreational and medical cannabis products across Canada, the United States, and Germany.
Canopy Growth operates through two segments — Global Cannabis and Other Consumer Products. The company generates revenue by selling dried flower, extracts, beverages, gummies, and vapes through a broad portfolio of consumer brands, serving both recreational buyers and medical patients across multiple markets.
Incorporated in 2009 and rebranded to its current name in 2015, Canopy Growth is headquartered in Smiths Falls, Canada.
- Dried cannabis flower and pre-rolls
- Cannabis extracts, concentrates, and vapes
- Cannabis-infused beverages and gummies
- Medical cannabis products under Spectrum Therapeutics
Is CGC a Good Stock to Buy?
UQS Score rates CGC as Poor overall.
Among the five pillars, Risk is the relative standout — suggesting the balance sheet or near-term operational exposure is not at the extreme end of concern for a company in this stage of the cannabis industry.
Quality, Moat, and Growth all register as Weak, reflecting the ongoing profitability and competitive challenges common across the cannabis sector. Valuation is rated Elevated, adding further caution.
See the exact pillar breakdown and full financial metrics by signing up for a Pro account. Sign up free →
Past performance does not guarantee future results. UQS Score is based on fundamental data and is not a buy/sell recommendation.
Does CGC pay dividends?
No — Canopy Growth Corporation does not currently pay a dividend.
Canopy Growth does not currently pay a dividend. At this stage of its development, the company prioritizes preserving capital and working toward sustainable operations rather than returning cash to shareholders.
When does CGC report earnings?
Canopy Growth reports earnings on a quarterly cadence, consistent with standard practice for TSX- and Nasdaq-listed companies.
The company has faced persistent revenue and profitability headwinds as the Canadian cannabis market remains intensely competitive. Progress toward operational efficiency has been gradual, and results have reflected the broader pressures facing the sector.
For the most recent quarter's results and guidance, visit Canopy Growth's investor relations page directly.
CGC Price History
-99.6% over 5Y
Monthly close, adjusted for stock splits and dividend reinvestment.
What if I invested in Canopy Growth Corporation?
Based on Canopy Growth Corporation's historical closing prices, adjusted for stock splits and dividend reinvestment. Past performance does not guarantee future results. This is for informational purposes only and is not financial advice.
Frequently Asked Questions
What does Canopy Growth do?
Canopy Growth produces and sells cannabis and hemp-based products for recreational and medical use. Its portfolio spans dried flower, extracts, beverages, gummies, and vapes, sold under numerous consumer brands in Canada, the United States, and Germany.
Does CGC pay dividends?
No, CGC does not pay a dividend. The company is focused on managing costs and working toward profitability, making capital preservation the priority over shareholder distributions at this time.
When does CGC report earnings?
Canopy Growth follows a quarterly reporting schedule. For exact dates and the most recent results, check the investor relations section of the company's official website.
Is CGC a good stock to buy?
UQS Score rates CGC as Poor, with Weak readings across Quality, Moat, and Growth pillars, and an Elevated Valuation. The Risk pillar is the relative bright spot. Investors should review the full pillar breakdown before drawing conclusions.
Is CGC overvalued?
The UQS Valuation pillar for CGC is rated Elevated, suggesting the current market price may not be well-supported by the company's underlying fundamentals relative to peers. Pro members can view the detailed valuation metrics.
What is CGC's market cap bracket?
Canopy Growth is classified as a small-cap company, placing it in a segment of the market that typically carries higher volatility and liquidity risk compared to large- or mega-cap peers.
Is CGC a long-term quality investment?
As a long-term quality indicator, CGC's Poor UQS Score — driven by Weak Quality, Moat, and Growth pillars — signals meaningful fundamental challenges. Long-term investors should weigh these structural concerns carefully alongside any sector-level thesis.
What sector does CGC belong to?
Canopy Growth is classified under the Healthcare sector, reflecting its medical cannabis operations, though it also competes in the consumer cannabis market. The sector context matters when comparing its UQS pillar ratings to peers.
Unlock Full CGC Analysis
Sign in to unlock the detailed analysis behind the UQS Score.
- ✓View the complete UQS pillar score breakdown for CGC
- ✓Access detailed financial metrics behind each pillar rating
- ✓Compare CGC side-by-side with sector peers
- ✓Track score changes as new earnings data is released
Pro Analysis
CGC — Score History
| Date | UQS | Quality | Moat | Growth | Risk | Value | Change |
|---|---|---|---|---|---|---|---|
| May 22, 2026 | 19.3 | 3.7 | 11.0 | 25.0 | 70.7 | 0.0 | +5.9 |
| Apr 2, 2026 | 13.4 | 0.0 | 11.0 | 0.0 | 70.7 | 0.0 | — |
CGC — Pillar Breakdown
Quality
— 3.7/100 (25%)Canopy Growth Corporation currently shows below-average quality metrics, suggesting challenges with profitability.
How effectively capital is deployed to generate returns.
Profitability relative to shareholders' equity.
Ability to convert revenue into operating profit.
Bottom-line profit as a share of revenue.
Asset productivity — how much gross profit each dollar of assets generates.
Free cash flow relative to market value.
Growth
— 25.0/100 (20%)Canopy Growth Corporation faces growth headwinds with declining or stagnant revenue trends.
Revenue trajectory over the last twelve months.
Compound annual revenue growth rate over 3 years.
Year-over-year earnings per share growth.
Analyst consensus for future revenue growth.
Risk
— 70.7/100 (15%)Canopy Growth Corporation maintains a reasonable risk profile with manageable debt levels.
Debt levels relative to earnings capacity.
Total debt relative to shareholder equity.
Short-term liquidity — ability to pay near-term obligations.
Earnings capacity relative to interest payments.
Valuation
— 0.0/100 (15%)Canopy Growth Corporation appears expensively valued relative to its fundamentals and growth prospects.
Moat
— 11/100 (25%)Canopy Growth Corporation operates in a highly competitive environment with limited sustainable advantages. The Moat pillar evaluates competitive advantages across five dimensions: Switching Costs, Network Effects, Cost Advantage, Intangible Assets, and Scale & Ecosystem. Sign in to customize moat ratings for CGC.
Score Composition
Financial Data
More Stock Analysis
How is the CGC UQS Score Calculated?
The UQS (Unified Quality Score) for Canopy Growth Corporation is calculated using a proprietary 6-pillar framework with 29 financial metrics. Each pillar evaluates a different dimension on a 0–100 scale, then combines into a single weighted score. Scoring thresholds are calibrated per sector. Momentum is an optional Pro toggle — without it, you get the 5-pillar / 25-metric core shown below.
Quality (25%) measures profitability and capital efficiency — ROIC, ROE, margins, GP/Assets, and FCF Yield.
Moat (25%) assesses Canopy Growth Corporation's competitive advantages across switching costs, network effects, cost advantages, intangible assets, and ecosystem scale.
Growth (20%) tracks revenue trajectory and earnings momentum, combining historical results with analyst forward estimates.
Risk (15%) is inversely scored — lower leverage and strong balance sheet health result in higher scores.
Valuation (15%) measures whether Canopy Growth Corporation is fairly priced using earnings yield, price-to-FCF, PEG ratio, and EV/EBITDA relative to sector peers.
Six investor-inspired presets are available, each with different pillar weights: Balanced, Buffett, Munger, Lynch, Cathie Wood, and Graham. The public score shown here uses the Balanced preset. Learn more in our FAQ.